Enhanced inhibition of syngeneic murine tumors by combinatorial therapy with genetically engineered HSV-1 expressing CCL2 and IL-12.

Source:http://linkedlifedata.com/resource/pubmed/id/15678154

Download in:

View as

General Info

PMID
15678154